Ivermectin vs Permethrin for Scabies

• by Kathryn Wighton

• March 3, 2026

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

• by Andrea Surnit

• May 20, 2026

• 4 min

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

• by Kathryn Wighton

• June 30, 2026

• 5 min

Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials

• by Melinda J. Gooderham, H. Chih-ho Hong, Charles Lynde, Yvette Miller-Monthrope, Vimal H. Prajapati, Julien Ringuet, Irina Turchin, Jensen Yeung, Kim A. Papp

• July 14, 2026